Sign in
Not yet taking people in United StatesPhase 1/2

Acute Nicotine Gum and Auditory Brain Responses in Adults With Chronic Tinnitus

Key facts

Who runs it
San Diego State University
Where
San Diego, United StatesSee the site
Trial code
Status
Not yet recruiting
Phase
Phase 1/2
People taking part
20 people, planned
Started
1 Nov 2026
Expected to end
31 May 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Nicotine polacrilex gum 4 mg
  • Placebo gum
Record updated
6 November 2026

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Non-smoking adult, defined as fewer than 100 cigarettes in a lifetime and none in the past year, with a Fagerstrom Test for Nicotine Dependence score of 2 or less and a negative urinary cotinine test
  • Chronic subjective tinnitus of at least 6 months' duration

Who cannot take part

  • Unstable cardiovascular disease
  • Any condition precluding the psychoacoustic tasks
  • Current or recent tobacco or nicotine use
  • Pregnancy or breastfeeding

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Where in United States

  • San Diego State UniversitySan Diego, United StatesContact: Xianhui WangNot yet recruiting

About the trial

What the trial wants to find out

This study tests whether a single dose of nicotine gum changes brain responses to sounds and the ability to detect target sounds in non-smoking adults with chronic tinnitus. In a double-blind, placebo-controlled, within-subject crossover design, each participant attends two sessions and receives a single 4 mg dose of nicotine polacrilex gum at one session and a flavor-matched placebo gum at the other, in random order. After gum administration, EEG is recorded at rest and during an active auditory oddball task. The primary measures are the P3 brain response (amplitude and latency) and oddball task accuracy and reaction time.

The 2 groups in the trial

  • Nicotine gum (4 mg)Treatment being tested

    Single 4 mg dose of nicotine polacrilex gum, chewed for 20 minutes at 1 Hz using the standardized administration protocol.

    Treatment: Nicotine polacrilex gum 4 mg

  • Placebo gumPlacebo, for comparison

    Flavor-, color-, shape-, and texture-matched placebo gum, chewed under the identical protocol.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Randomized, Double-Blind, Placebo-Controlled, Within-Subject Crossover Trial of a Single 4 mg Dose of Nicotine Polacrilex Gum on Auditory Oddball P3, Oddball Task Performance, and Resting-State EEG in Non-Smoking Adults With Chronic Tinnitus
Criteria questions
Built from NCT07877701, who can take part
Record updated
6 November 2026